JPWO2021163477A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021163477A5 JPWO2021163477A5 JP2022549088A JP2022549088A JPWO2021163477A5 JP WO2021163477 A5 JPWO2021163477 A5 JP WO2021163477A5 JP 2022549088 A JP2022549088 A JP 2022549088A JP 2022549088 A JP2022549088 A JP 2022549088A JP WO2021163477 A5 JPWO2021163477 A5 JP WO2021163477A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- chain
- val
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062976655P | 2020-02-14 | 2020-02-14 | |
| US62/976,655 | 2020-02-14 | ||
| US202063060340P | 2020-08-03 | 2020-08-03 | |
| US63/060,340 | 2020-08-03 | ||
| PCT/US2021/017852 WO2021163477A1 (en) | 2020-02-14 | 2021-02-12 | Hla class i-restricted t cell receptors against ras with g12v mutation |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023526149A JP2023526149A (ja) | 2023-06-21 |
| JP2023526149A5 JP2023526149A5 (https=) | 2024-02-26 |
| JPWO2021163477A5 true JPWO2021163477A5 (https=) | 2024-02-26 |
| JP7735285B2 JP7735285B2 (ja) | 2025-09-08 |
Family
ID=74860482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022549088A Active JP7735285B2 (ja) | 2020-02-14 | 2021-02-12 | Ｇ１２ｖ突然変異ｒａｓに対するｈｌａクラスｉ拘束性ｔ細胞受容体 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230082787A1 (https=) |
| EP (1) | EP4103598A1 (https=) |
| JP (1) | JP7735285B2 (https=) |
| KR (1) | KR20220143875A (https=) |
| CN (1) | CN115315441A (https=) |
| AU (1) | AU2021220957A1 (https=) |
| BR (1) | BR112022015897A2 (https=) |
| CA (1) | CA3167382A1 (https=) |
| GB (1) | GB2610311B (https=) |
| MX (1) | MX2022009825A (https=) |
| TW (1) | TWI902755B (https=) |
| WO (1) | WO2021163477A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL305393A (en) | 2021-02-25 | 2023-10-01 | Alaunos Therapeutics Inc | Recombinant vectors comprising polycistronic expression cassettes and methods of use thereof |
| EP4334361A1 (en) | 2021-05-05 | 2024-03-13 | Immatics Biotechnologies GmbH | Antigen binding proteins specifically binding prame |
| US20250145950A1 (en) | 2022-02-01 | 2025-05-08 | Alaunos Therapeutics, Inc. | Methods for Activation and Expansion of T Cells |
| WO2023232785A1 (en) * | 2022-05-30 | 2023-12-07 | Hs Diagnomics Gmbh | Common tumor-specific t cell receptors |
| CN118852452A (zh) * | 2023-04-28 | 2024-10-29 | 北京鼎成肽源生物技术有限公司 | 靶向kras g12突变的tcr分子和细胞及其应用 |
| WO2025056681A1 (en) * | 2023-09-15 | 2025-03-20 | Medigene Immunotherapies Gmbh | T-CELL RECEPTOR AGAINST mKRAS7-16 G12V AND G12C |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003265948B8 (en) | 2002-09-06 | 2009-09-03 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy |
| US8383099B2 (en) | 2009-08-28 | 2013-02-26 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Adoptive cell therapy with young T cells |
| WO2012129201A1 (en) | 2011-03-22 | 2012-09-27 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of growing tumor infiltrating lymphocytes in gas-permeable containers |
| MX384919B (es) | 2014-11-26 | 2025-03-14 | Us Health | Receptores de células t de kras anti-mutado. |
| JP7185524B2 (ja) * | 2015-09-15 | 2022-12-07 | アメリカ合衆国 | Ｈｌａ－ｃｗ８拘束性の変異ｋｒａｓを認識するｔ細胞受容体 |
| US20170319638A1 (en) * | 2016-05-06 | 2017-11-09 | Virttu Biologics Limited | Treatment of cancer |
| EP3684799A1 (en) | 2017-09-20 | 2020-07-29 | The U.S.A. as represented by the Secretary, Department of Health and Human Services | Hla class ii restricted t cell receptors against mutated ras |
| EP3720478A1 (en) * | 2017-12-04 | 2020-10-14 | The United States of America, as represented by the Secretary, Department of Health and Human Services | Hla class i-restricted t cell receptors against mutated ras |
| EP3731861A1 (en) * | 2017-12-29 | 2020-11-04 | Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft | T cell receptors for tumor specific proteasome splice variants and uses thereof |
-
2021
- 2021-02-12 AU AU2021220957A patent/AU2021220957A1/en active Pending
- 2021-02-12 CN CN202180014281.4A patent/CN115315441A/zh active Pending
- 2021-02-12 EP EP21710740.8A patent/EP4103598A1/en active Pending
- 2021-02-12 WO PCT/US2021/017852 patent/WO2021163477A1/en not_active Ceased
- 2021-02-12 TW TW110105193A patent/TWI902755B/zh active
- 2021-02-12 MX MX2022009825A patent/MX2022009825A/es unknown
- 2021-02-12 JP JP2022549088A patent/JP7735285B2/ja active Active
- 2021-02-12 US US17/799,193 patent/US20230082787A1/en active Pending
- 2021-02-12 CA CA3167382A patent/CA3167382A1/en active Pending
- 2021-02-12 GB GB2211757.6A patent/GB2610311B/en active Active
- 2021-02-12 KR KR1020227031589A patent/KR20220143875A/ko active Pending
- 2021-02-12 BR BR112022015897A patent/BR112022015897A2/pt unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Saada et al. | Subepithelial myofibroblasts are novel nonprofessional APCs in the human colonic mucosa | |
| Lazetic et al. | Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits | |
| KR101760277B1 (ko) | Ｔ-세포 수용체 | |
| Matsumoto et al. | Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes. | |
| Spits et al. | Antigen‐specific cytotoxic T cell and antigen‐specific proliferating T cell clones can be induced to cytolytic activity by monoclonal antibodies against T3 | |
| Lane et al. | Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation. | |
| AU696664B2 (en) | CTLA4 mutant molecules and uses thereof | |
| JP3700859B2 (ja) | Ｌａｇ−３タンパク質の可溶性ポリペプチドフラクション；製造方法、治療用製剤、抗イディオタイプ抗体 | |
| JP7735285B2 (ja) | Ｇ１２ｖ突然変異ｒａｓに対するｈｌａクラスｉ拘束性ｔ細胞受容体 | |
| KR20220066075A (ko) | T-세포 조절 폴리펩타이드 및 이의 사용 방법 | |
| KR20210104673A (ko) | 다량체 t-세포 조절 폴리펩타이드 및 이의 사용 방법 | |
| Honjo et al. | Unique ligand-binding property of the human IgM Fc receptor | |
| US20220089680A1 (en) | Multimeric t-cell modulatory polypeptides and methods of use thereof | |
| GB2610069A (en) | HLA class II-restricted T cell receptors against RAS with G12V mutation | |
| Terawaki et al. | Specific and high-affinity binding of tetramerized PD-L1 extracellular domain to PD-1-expressing cells: possible application to enhance T cell function | |
| JPWO2021163477A5 (https=) | ||
| KR20230084524A (ko) | G13d 돌연변이를 갖는 ras에 대한 hla 클래스 ii-제한된 dq t 세포 수용체 | |
| WO1990013644A2 (en) | Soluble cytoplasmic domain of human cd2 receptor | |
| DiGiusto et al. | An analysis of sequence variation in the β chain framework and complementarity determining regions of an allo-reactive T cell receptor | |
| EP4688164A1 (en) | Liver-specific car for use against immunologic rejection | |
| WO2024117781A1 (ko) | Cd137 세포외 도메인을 포함하는 융합단백질, 이를 발현하는 면역세포 및 이의 용도 | |
| JPWO2021163434A5 (https=) | ||
| Kaplan et al. | Production and characterization of soluble and transmembrane murine CD2. Demonstration that CD48 is a ligand for CD2 and that CD48 adhesion is regulated by CD2. | |
| US20220184130A1 (en) | Artificial signalling molecule | |
| EP1016714B1 (en) | Novel plasmid dna containing reporter gene dna and use of the same |